Our GPDT® formula, rich in isoprenoid phenolic and chlorophyll derivatives, is study proven to support immune health and cellular function, with effect enhanced by exposure to daylight. Patented granted and pending in multiple countries, GPDT® is a trademark co-developed by Oxperial and officially registered in Taiwan and the UK.
Our GPDT® formula uses a cutting-edge, patented extraction process to ensure the highest quality of compounds for health supplement. With multi-level frequency conversion ultrasonic technology and low-temperature vacuum extraction, we preserve the powerful properties of Taiwan green propolis and herbal extracts, delivering maximum potency for immune and cellular health.
Vacuum wall breaking extraction
Low temperature vacuum concentration
Low temperature freeze drying
Low temperature spray granulation
Embedded coated particles
Specially formulated chylomicrons
GPDT ® is supported by extensive scientific evidence in recent decade, highlighting the anti- tumour effects of its core components.
Inhibit tumour growth and trigger cancer cell death using light activation.
Active compounds that help suppresses tumour growth, reduce metastasis, and boosts immune responses.
Non-invasive cancer treatment, showing better tumor cell death and immune stimulation compared to standard therapies.
GPDT® is the world’s first scientifically-backed formula offering a natural and effective way to support cellular health and resilience, based on research.
Chlorophyll derivatives
to harness natural daylight for targeted cellular level effects.
Green propolis
a powerful natural compound, to enhance immune modulation and antioxidant capacity.
Daylight-based PDT
optimized for daily use, making the mechanism accessible and practical.
28th International Symposium on Molecular Medicine, 8 – 10 November 2024
Pharmaceuticals 2024 conference, 27 – 29 November 2024
Future Science OA, 2025 – Under review
https://doi.org/10.1016/j.pdpdt.2019.04.033
https://www.mdpi.com/1420-3049/28/14/5344
https://www.mdpi.com/2072-6643/13/8/2594
https://doi.org/10.1155/2013/658370
https://doi.org/10.1111/j.2042-7158.2011.01331.x
https://www.mdpi.com/2072-6643/15/21/4494
https://doi.org/10.1111/j.2042-7158.2011.01331.x
email:office@oxperial.co.uk
address:46 Woodstock Rd, Oxford, UK OX2 6HT